SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-012774
Filing Date
2024-04-02
Accepted
2024-04-02 16:05:43
Documents
24
Period of Report
2024-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46338
2 ex99-1.htm EX-99.1 195242
3 ex99-2.htm EX-99.2 316462
4 ex99-2_001.jpg GRAPHIC 14545
5 ex99-2_002.jpg GRAPHIC 6265
6 ex99-2_003.jpg GRAPHIC 12300
7 ex99-2_004.jpg GRAPHIC 14128
8 ex99-2_005.jpg GRAPHIC 20323
9 ex99-2_006.jpg GRAPHIC 15291
10 ex99-2_007.jpg GRAPHIC 12857
11 ex99-2_008.jpg GRAPHIC 15896
  Complete submission text file 0001493152-24-012774.txt   1010117

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE bctx-20240401.xsd EX-101.SCH 3750
13 XBRL DEFINITION FILE bctx-20240401_def.xml EX-101.DEF 26591
14 XBRL LABEL FILE bctx-20240401_lab.xml EX-101.LAB 36647
15 XBRL PRESENTATION FILE bctx-20240401_pre.xml EX-101.PRE 25215
28 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5633
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-40101 | Film No.: 24814184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)